Better prediction of prognosis for patients with nasopharyngeal carcinoma using primary tumor volume

Abstract

BACKGROUNDHeterogeneity of primary tumor volume within tumors of the same classification indicates a need to elucidate the effects of primary tumor volume on treatment outcomes in patients with nasopharyngeal carcinoma (NPC).METHODSFrom 1994 through 1996, 129 patients with newly diagnosed NPC who were treated with high‐dose radiotherapy were enrolled in the study. Computed tomography‐derived primary tumor volume was measured using the summation‐of‐area technique. Correlations between American Joint Committee on Cancer (AJCC) disease stage, primary tumor volume, and disease‐specific survival were assessed using a Cox regression model. Cross‐validation based on receiver operating characteristic (ROC) curve also was examined.RESULTSCompared with the AJCC staging system and the TNM classification system, primary tumor volume was better at determining cumulative survival for patients with NPC. Hazard ratios increased with tumor volume, ranging from 6.68 (95% confidence interval [95% CI], 1.89–23.67) for tumor volumes between 20–40 mL, 18.03 (95% CI, 4.80–67.75) for tumor volumes between 40–60 mL, and 26.06 (95% CI, 7.70–88.20) for tumor volumes > 60 mL. With both tumor volume and T classification in the same Cox regression model, only tumor volume remained statistically significant in the prognosis of NPC. The validation results with ROC curves also revealed that, in predicting patient outcome, primary tumor volume (area under the ROC = 83.33%) was superior to disease stage (area under the ROC = 66.53%) and TNM classification (area under the ROC = 58.61%).CONCLUSIONSThe incorporation of primary tumor volume may lead to a further refinement of the current AJCC staging system, particularly for patients with large primary tumor volumes (> 60 mL), who require more aggressive treatment. Cancer 2004. © 2004 American Cancer Society.

Prognostic Factors on Overall Survival of Newly Diagnosed Metastatic Nasopharyngeal Carcinoma

“…T-stage, N-stage and metastasis number are all the representations of tumor burden. A lot of articles reported that the greater the tumor load, the worse the prognosis in NPC (Chen et al, 2004;Lee et al, 2008;Chen et al, 2011). Increased number of clonogenic tumor cells is related to tumor hypoxia and possibly alters levels of intercellular communication factors, which are associated with insensitivity to radiotherapy or chemotherapy (Johnson et al, 1995).…”

Aurora-A is an efficient marker for predicting poor prognosis in human nasopharyngeal carcinoma with aggressive local invasion: 208 cases with a 10-year follow-up from a single institution

“…The possible etiological factors identified for NPC are genetic susceptibility, Epstein-Barr virus (EBV) infection and environmental risk factors. Although plasma EBV DNA quantification has been recommended as an independent biomarker for the prediction of survival (3,4), currently the prediction of prognosis for patients with NPC mainly depends on clinical staging. However, NPC patients with the same clinical stage often present different clinical outcomes, suggesting that the clinical staging is insufficient for accurate prediction of the prognosis of NPC.…”

Small hairpin RNA-mediated Krüppel-like factor 8 gene knockdown inhibits invasion of nasopharyngeal carcinoma

“…NPC is a serious healthcare problem (14), more frequently occurring in Southern China, which presents early metastasis features. At present, radiation therapy is the main NPC treatment.…”